Amlodipine/candesartan cilexetil - Shin Poong PharmaceuticalsAlternative Names: CANDEAMLO; Candersartan cilexetil/amlodipine - Shin Poong Pharmaeuticals
Latest Information Update: 17 Feb 2017
At a glance
- Originator Shin Poong Pharmaceutical
- Class Antihypertensives; Benzimidazoles; Biphenyl compounds; Dihydropyridines; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Essential hypertension